no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Adjuvant single agent Carboplatin-therapy for clinical stage I seminoma. An alternative treatment-option?
|
Nöst, G. |
|
1998 |
37 |
6 |
p. 629-634 |
article |
2 |
Adjuvant single agent Carboplatin-therapy for clinical stage I seminoma. An alternative treatment-option?
|
Nöst, G. |
|
1998 |
37 |
6 |
p. 629-634 |
article |
3 |
Diagnostic of non-palpable testis in children: laparoscopy or magnetic resonance imaging?
|
Siemer, S. |
|
1998 |
37 |
6 |
p. 648-652 |
article |
4 |
Diagnostic of non-palpable testis in children: laparoscopy or magnetic resonance imaging?
|
Siemer, S. |
|
1998 |
37 |
6 |
p. 648-652 |
article |
5 |
EditorialDGU-/BDU-Arbeitskreis Schmerztherapie/Supportivtherapie/ Lebensqualität
|
Harzmann, R. |
|
1998 |
37 |
6 |
p. 653 |
article |
6 |
EditorialDGU-/BDU-Arbeitskreis Schmerztherapie/Supportivtherapie/ Lebensqualität
|
Harzmann, R. |
|
1998 |
37 |
6 |
p. 653 |
article |
7 |
Grundlagen der Tumorschmerztherapie
|
Weckermann, D. |
|
1998 |
37 |
6 |
p. 654-659 |
article |
8 |
Grundlagen der Tumorschmerztherapie
|
Weckermann, D. |
|
1998 |
37 |
6 |
p. 654-659 |
article |
9 |
Inzidenz und klinische Bedeutung von falsch-negativen Sextanten-Biopsien der Prostata
|
|
|
1998 |
37 |
6 |
p. 660-662 |
article |
10 |
Inzidenz und klinische Bedeutung von falsch-negativen Sextanten-Biopsien der Prostata
|
, |
|
1998 |
37 |
6 |
p. 660-662 |
article |
11 |
Ist der Hodentumor ein „Model“?(„Model“, engl.: Vorführdame, Mannequin)
|
Albers, P. |
|
1998 |
37 |
6 |
p. 591-592 |
article |
12 |
Ist der Hodentumor ein „Model“?(„Model“, engl.: Vorführdame, Mannequin)
|
Albers, P. |
|
1998 |
37 |
6 |
p. 591-592 |
article |
13 |
Jahrestagung des Arbeitskreises NierentransplantationJena vom 19. bis 20.6.1998
|
Schubert, J. |
|
1998 |
37 |
6 |
p. 673-687 |
article |
14 |
Jahrestagung des Arbeitskreises NierentransplantationJena vom 19. bis 20.6.1998
|
Schubert, J. |
|
1998 |
37 |
6 |
p. 673-687 |
article |
15 |
Late toxicity after treatment for testicular germ cell cancer
|
Jakob, A. |
|
1998 |
37 |
6 |
p. 635-647 |
article |
16 |
Late toxicity after treatment for testicular germ cell cancer
|
Jakob, A. |
|
1998 |
37 |
6 |
p. 635-647 |
article |
17 |
Leitlinien zur Kinderurologie¶Teil 2
|
|
|
1998 |
37 |
6 |
p. 663-671 |
article |
18 |
Leitlinien zur Kinderurologie¶Teil 2
|
, |
|
1998 |
37 |
6 |
p. 663-671 |
article |
19 |
Marker-positive patients with germ-cell tumors: when is residual tumor resection useful?
|
Weinknecht, S. |
|
1998 |
37 |
6 |
p. 621-624 |
article |
20 |
Marker-positive patients with germ-cell tumors: when is residual tumor resection useful?
|
Weinknecht, S. |
|
1998 |
37 |
6 |
p. 621-624 |
article |
21 |
Molecular pathogenesis and molecular prognosis factors of the testicular tumor
|
Heidenreich, A. |
|
1998 |
37 |
6 |
p. 593-608 |
article |
22 |
Molecular pathogenesis and molecular prognosis factors of the testicular tumor
|
Heidenreich, A. |
|
1998 |
37 |
6 |
p. 593-608 |
article |
23 |
Positron-emission tomography with 18F-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in the diagnosis of retroperitoneal lymph-node metastases from testicular tumors
|
Müller-Mattheis, V. |
|
1998 |
37 |
6 |
p. 609-620 |
article |
24 |
Positron-emission tomography with 18F-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in the diagnosis of retroperitoneal lymph-node metastases from testicular tumors
|
Müller-Mattheis, V. |
|
1998 |
37 |
6 |
p. 609-620 |
article |
25 |
Testicular tumors. Mortality and recurrence after inadequate therapy
|
Albers, P. |
|
1998 |
37 |
6 |
p. 625-628 |
article |
26 |
Testicular tumors. Mortality and recurrence after inadequate therapy
|
Albers, P. |
|
1998 |
37 |
6 |
p. 625-628 |
article |
27 |
URO-Telegramm
|
|
|
1998 |
37 |
6 |
p. 672 |
article |
28 |
URO-Telegramm
|
, |
|
1998 |
37 |
6 |
p. 672 |
article |